Latest Community Engagement News

Promisia Healthcare reported a 58% jump in underlying EBITDAF to $6.6 million for FY26, driven by improved occupancy and operational upgrades. The company introduced a dividend policy tied to operating free cash flow, signalling confidence in sustained cash generation.

Sunstone Metals continues to expand its Bramaderos gold-copper resource in Ecuador, with recent drilling at Porotillo delivering long, consistent mineralised intersections outside the existing 3.6Moz resource. The company aims to upgrade a significant exploration target to a JORC resource later this year.

Nova Minerals has launched a major 2026 exploration campaign at its Estelle Project in Alaska, combining a 10,000-metre drilling program with advancing antimony production backed by US$43.4 million in U.S. Department of War funding.

Neuren Pharmaceuticals reported a 15% rise in 2025 royalties from DAYBUE®, boosted by strong US sales and a new powder formulation launch. The company is progressing its pivotal Phase 3 trial for NNZ-2591 in Phelan-McDermid syndrome and reassessing capital management amid solid cash reserves.

St Barbara Limited has secured final investment decisions for its New Simberi expansion in Papua New Guinea and the Touquoy Restart in Nova Scotia, targeting a production surge exceeding 200% over the next four years.

Tivan Limited has formalised binding joint venture agreements with Timor-Leste’s state-owned Murak Rai Timor to develop the Baucau and Ossu copper-gold projects, targeting maiden drilling at Ossu in late 2026.

Hillgrove Resources has secured the right to earn an 80% stake in the Mutooroo Copper Project through a farm-in deal with Havilah Resources, leveraging its Kanmantoo processing plant to potentially boost copper output with lower capital risk.

Sunstone Metals continues to deliver promising gold-copper intersections at its Bramaderos project in Ecuador, with recent Porotillo drilling reinforcing potential to expand the current 3.6Moz resource ahead of a resource update later this year.

AFT Pharmaceuticals posted a 22% revenue jump to NZ$254.7 million and a 39% increase in operating profit to a record NZ$24.4 million for FY26, exceeding guidance. The company targets over NZ$300 million revenue for FY27, fueled by international expansion and a deepening R&D pipeline.

MB Gold has delivered its widest significant gold intercept to date at the Twin Veins Prospect, with drilling ongoing and a second phase planned to expand exploration across the Marble Bar Gold Project.

Geopacific Resources' updated 2026 DFS for the Woodlark Gold Project reveals a 19% rise in Mineral Resources to 1.98 million ounces and a new Ore Reserve of 1.2 million ounces, underpinning robust economics and a rapid 18-month payback.

Corella Resources has secured a transformative district-scale landholding in Western Australia's West Arunta, targeting niobium, rare earth elements, copper, and gold with a clear exploration roadmap.